Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Source :: Financial Services Monitor Worldwide. June 24, 2020
Publication Year :: 2020
Abstract: (GlobeNewswire) - June 23, 2020 Amsterdam, the Netherlands and Cambridge, MA Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices [...]

Subjects :: United States. Food and Drug Administration -- Technology application
United States. Center for Devices and Radiological Health -- Technology application
Defibrillators -- Technology application
Drug approval -- Technology application
Technology application
Banking, finance and accounting industries

Tools